How to buy ACADIA Pharmaceuticals (ACAD) stock

ACADIA Pharmaceuticals Inc is a biotechnology business based in the US. ACADIA Pharmaceuticals shares (ACAD) are listed on the NASDAQ and all prices are listed in US Dollars. ACADIA Pharmaceuticals employs 640 staff and has a trailing 12-month revenue of around 0.00.

ACADIA Pharmaceuticals stock price (NASDAQ: ACAD)

Use our graph to track the performance of ACAD stocks over time.

ACADIA Pharmaceuticals shares at a glance

• Key figures

Information last updated 2021-07-22.

Latest market close	$22.34
52-week range	$19.20 - $57.46
50-day moving average	$24.76
200-day moving average	$32.18
Wall St. target price	$27.21
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$-1.97

Buy ACADIA Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy ACADIA Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of ACADIA Pharmaceuticals Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

ACADIA Pharmaceuticals price performance over time

Historical closes compared with the close of $22.34 from 2021-05-28

1 week (2021-07-17)	N/A
1 month (2021-06-28)	-11.80%
3 months (2021-04-28)	7.56%
6 months (2021-01-24)	N/A

1 year (2020-07-24)	N/A
2 years (2019-07-24)	N/A
3 years (2018-07-24)	N/A
5 years (2016-07-24)	N/A

ACADIA Pharmaceuticals financials

Revenue TTM	$458.2 million
Gross profit TTM	$154.9 million
Return on assets TTM	-17.56%
Return on equity TTM	-42.63%
Profit margin	-56.74%
Book value	$3.63
Market capitalisation	$3.6 billion

TTM: trailing 12 months

Shorting ACADIA Pharmaceuticals shares

There are currently 8.2 million ACADIA Pharmaceuticals shares held short by investors – that's known as ACADIA Pharmaceuticals's "short interest". This figure is 36.9% up from 6.0 million last month.

There are a few different ways that this level of interest in shorting ACADIA Pharmaceuticals shares can be evaluated.

ACADIA Pharmaceuticals's "short interest ratio" (SIR)

ACADIA Pharmaceuticals's "short interest ratio" (SIR) is the quantity of ACADIA Pharmaceuticals shares currently shorted divided by the average quantity of ACADIA Pharmaceuticals shares traded daily (recently around 2.3 million). ACADIA Pharmaceuticals's SIR currently stands at 3.5. In other words for every 100,000 ACADIA Pharmaceuticals shares traded daily on the market, roughly 3500 shares are currently held short.

However ACADIA Pharmaceuticals's short interest can also be evaluated against the total number of ACADIA Pharmaceuticals shares, or, against the total number of tradable ACADIA Pharmaceuticals shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case ACADIA Pharmaceuticals's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 ACADIA Pharmaceuticals shares in existence, roughly 50 shares are currently held short) or 0.0696% of the tradable shares (for every 100,000 tradable ACADIA Pharmaceuticals shares, roughly 70 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against ACADIA Pharmaceuticals.

Find out more about how you can short ACADIA Pharmaceuticals stock.

ACADIA Pharmaceuticals share dividends

We're not expecting ACADIA Pharmaceuticals to pay a dividend over the next 12 months.

ACADIA Pharmaceuticals share price volatility

Over the last 12 months, ACADIA Pharmaceuticals's shares have ranged in value from as little as $19.2 up to $57.46. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while ACADIA Pharmaceuticals's is 0.735. This would suggest that ACADIA Pharmaceuticals's shares are less volatile than average (for this exchange).

ACADIA Pharmaceuticals overview

ACADIA Pharmaceuticals Inc. , a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis; Trofinetide, a novel synthetic analog for the treatment of Rett syndrome; ACP-044, a novel first-in-class orally administered non-opioid analgesic for treating acute and chronic pain; and ACP-319, a positive allosteric modulator of the muscarinic receptor for treating cognition and schizophrenia. It is also developing pimavanserin as a treatment for dementia-related psychosis and as an adjunctive treatment for schizophrenia; and pimavanserin as an adjunctive treatment for major depressive disorder. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California. .

Frequently asked questions

What percentage of ACADIA Pharmaceuticals is owned by insiders or institutions?
Currently 0.397% of ACADIA Pharmaceuticals shares are held by insiders and 93.672% by institutions. How many people work for ACADIA Pharmaceuticals?
Latest data suggests 640 work at ACADIA Pharmaceuticals. When does the fiscal year end for ACADIA Pharmaceuticals?
ACADIA Pharmaceuticals's fiscal year ends in December. Where is ACADIA Pharmaceuticals based?
ACADIA Pharmaceuticals's address is: 12830 El Camino Real, San Diego, CA, United States, 92130 What is ACADIA Pharmaceuticals's ISIN number?
ACADIA Pharmaceuticals's international securities identification number is: US0042251084 What is ACADIA Pharmaceuticals's CUSIP number?
ACADIA Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 004225108